Overview BLI400-302: A Safety and Efficacy Evaluation of BLI400 Laxative in Constipated Adults Status: Completed Trial end date: 2017-06-01 Target enrollment: Participant gender: Summary The objective of this study is to evaluate a daily dose of BLI400 Laxative for safety and efficacy versus placebo in constipated adults. Phase: Phase 3 Details Lead Sponsor: Braintree LaboratoriesTreatments: CatharticsLaxatives